Ventricular Assist Devices (VAD)

This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.

 

Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational device exemption (IDE) application to start an early feasibility study with a first-in-human trial of the 9 French (Fr) Impella ECP heart pump. Impella ECP, which stands for "expandable cardiac power," will be studied in high-risk percutaneous coronary intervention (PCI) patients.
News | Hemodynamic Support Devices | June 05, 2020
FDA Approves First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump
June 5, 2020 — Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational...
read more
Videos | Hemodynamic Support Devices | June 05, 2020
VIDEO: Demonstration of Abiomed Impella ECP 9 French Transcatheter Ventricular Assist Device
This is a quick animation demonstrating how the new 9 French Abiomed Impella ECP expands to approximately 18 French and...
read more
he U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Abiomed Impella RP catheter-based heart pump to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism (PE).  #COVID19 #SARScov2
Feature | Coronavirus (COVID-19) | June 01, 2020
Impella RP Granted FDA Emergency Use Authorization for COVID-19 Patients With Right Heart Failure
June 1, 2020 — The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the...
read more
FDA Class I Recall Issued for Medtronic HeartWare HVAD Pump
News | Ventricular Assist Devices (VAD) | May 29, 2020
Class I Recall Issued for Medtronic HeartWare HVAD Pump
May 29, 2020 — Medtronic is recalling its HeartWare HVAD left ventricular assist device (LVAD) pump outflow graft and...
read more
News | Artificial Heart | May 27, 2020
First Implantation of Carmat Total Artificial Heart in Denmark
May 27, 2020 — Carmat, a developer of the of a next generation advanced total artificial heart, announces the first...
read more
News | Artificial Heart | March 10, 2020
FDA Clears SynCardia 50cc Temporary Total Artificial Heart as Bridge to Transplant
March 10, 2020 —  The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total...
read more
News | Heart Failure | March 05, 2020
Abbott’s In-Development Fully Implantable Heart Pump System Earns FDA’s Breakthrough Device Designation
March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration (...
read more
he U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption (IDE) application to start a U.S. early feasibility study (EFS) of its total artificial heart.
News | Heart Failure | February 12, 2020
Carmat to initiate FDA U.S. Feasibility Study of Total Artificial Heart
February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption...
read more
Abiomed Impella pump catheters in the production line are placed in stands as they are completed for inspection.
Gallery | Hemodynamic Support Devices | February 10, 2020 | Dave Fornell, Editor
Photo Gallery of the Abiomed Impella Production Line
DAIC Editor Dave Fornell recently took a tour of the Abiomed Impella production line at its headquarters in Danvers,...
read more
Videos | Hemodynamic Support Devices | February 07, 2020
VIDEO: Door-to-Unloading (DTU) Trial May Change STEMI Care
Interview with Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and...
read more
Videos | Hemodynamic Support Devices | January 24, 2020
VIDEO: Tufts Uses a Hemodynamic Support Algorithm to Determine What Devices to Use
Navin Kapur, M.D., FAHA, FACC, FSCAI, director, Acute Mechanical Circulatory Support Program and executive director of...
read more
Videos | Cath Lab | January 09, 2020
VIDEO: The Role of Intensivists on the Cardiac Critical Care Team
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
read more
Videos | Hemodynamic Support Devices | January 09, 2020
VIDEO: Remote Smartphone Access to Impella Consoles Aids Patient Care and Tech Support
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, and Melissa...
read more
Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery. The new, less invasive approach is designed to provide surgeons a choice in surgical method for patients receiving the HeartMate 3 Left Ventricular Assist Device (LVAD).
News | Ventricular Assist Devices (VAD) | January 07, 2020
FDA Approves Less Invasive Surgical Approach for HeartMate 3 Heart Pump
January 7, 2020 — Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical...
read more
CentriMag
News | Hemodynamic Support Devices | November 04, 2019
Abbott Recalls CentriMag Circulatory Support System After 44 Injuries and One Death
November 4, 2019 — Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system error...
read more
© Copyright Wainscot Media. All Rights Reserved.